Jia Liu

Tumour-agnostic immunotherapy: aligning biological rationale, biomarker precision, and real-world implementation

Summary Tumour-agnostic immunotherapy has reshaped precision oncology by showing that treatment benefit can, in selected settings, be predicted by a shared biological state rather than anatomical origin. Microsatellite instability-high or mismatch repair-deficient cancer is the clearest example, with durable responses...

Designing for delivery: a Delphi study of feasibility-informed implementation strategies for a fear of cancer recurrence clinical pathway

Fear of cancer recurrence (FCR) is pervasive among cancer survivors, yet evidence-based care is rarely implemented. Clinical pathways offer a structured approach to translating evidence into practice. This study identified key implementation barriers, enablers, and strategies for feasibly integrating an FCR clinical pa...

A modular framework for antibody-drug conjugate biomarkers.

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database

A narrative review of emerging cancer treatment data, molecular profiling technologies, and existing clinicogenomic databases, focusing on how tumors are characterized, how subgroups are defined, and how demographic, lifestyle, and environmental factors are captured.